CLINICAL_TRIALS
trial_result
· 2017-12-26
Clinical Trial Update: A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis [Phase 3]
Summary
Phase 3 trial update for ocrelizumab in primary progressive multiple sclerosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis, Primary Progressive | Phase 3 | Status: COMPLETED | Results posted: 2017-12-26